Diabetes
Tirzepatide
Mounjaro
Generic nameTirzepatide
Brand nameMounjaro
Medication classGIP/GLP-1 receptor agonist
Typical adult example2.5–15 mg subcutaneous
FrequencyOnce weekly
Common uses
Recognition cues
- Type 2 diabetes
- Chronic weight management
EMS relevance
Assessment context
- GI adverse effects and reduced intake may contribute to dehydration.